Calumet (NASDAQ:CLMT) Director Daniel Sajkowski Sells 2,000 Shares of Stock

Calumet, Inc. (NASDAQ:CLMT) Director Daniel Sajkowski sold 2,000 shares of the business’s stock in a transaction on Tuesday, July 1st. The shares were sold at an average price of $15.77, for a total transaction of $31,540.00. Following the sale, the director directly owned 82,237 shares in the company, valued at approximately $1,296,877.49. This trade represents a 2.37% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.

Calumet Stock Down 6.6%

Shares of Calumet stock traded down $2.01 during midday trading on Friday, hitting $28.21. The company’s stock had a trading volume of 131,011 shares, compared to its average volume of 1,367,579. Calumet, Inc. has a 1-year low of $7.68 and a 1-year high of $30.35. The firm has a market capitalization of $2.45 billion, a P/E ratio of -65.58 and a beta of 1.24. The stock has a 50-day simple moving average of $22.92 and a 200-day simple moving average of $19.82.

Calumet (NASDAQ:CLMT) last announced its quarterly earnings data on Friday, February 27th. The oil and gas company reported ($0.43) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.67) by $0.24. The business had revenue of ($3,098.50) million during the quarter, compared to analysts’ expectations of $1.04 billion. During the same period in the prior year, the company posted ($0.47) earnings per share. The firm’s revenue was up 9.4% on a year-over-year basis. As a group, sell-side analysts predict that Calumet, Inc. will post -3.02 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on the stock. The Goldman Sachs Group increased their target price on shares of Calumet from $20.00 to $24.00 and gave the stock a “buy” rating in a research report on Friday, January 30th. TD Cowen reiterated a “hold” rating on shares of Calumet in a report on Thursday, January 29th. HC Wainwright reissued a “buy” rating and set a $33.00 price objective on shares of Calumet in a research report on Monday, November 10th. Wall Street Zen lowered Calumet from a “buy” rating to a “hold” rating in a research report on Sunday, December 14th. Finally, Weiss Ratings reiterated a “sell (d-)” rating on shares of Calumet in a report on Monday, December 29th. Four analysts have rated the stock with a Buy rating, three have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $22.83.

Calumet News Roundup

Here are the key news stories impacting Calumet this week:

• Positive Sentiment: Q4 EPS beat — Calumet reported GAAP EPS of ($0.43) vs. consensus ($0.67), reducing downside surprise and supporting near‑term sentiment. Read More.
• Positive Sentiment: FY2025 operational and financial improvements — management reported Adjusted EBITDA with tax attributes of $293.3M, ~$222M of recourse debt reduction, roughly $100M in cost savings driving free cash flow, and a planned Montana Renewables expansion on track for Q2 2026; these items de‑risk the business and support medium‑term valuation. Read More.
• Neutral Sentiment: Analyst and preview coverage mixed — pre‑earnings pieces and recent analyst notes (Goldman raised its PT; other firms varied between buy/hold/sell) helped set expectations ahead of the release but did not provide new guidance. Read More.
• Negative Sentiment: Insider selling — Director Daniel J. Sajkowski disclosed multiple recent sales (several 20k‑share tranches), materially trimming his stake; visible insider selling can be perceived negatively even if for personal/liquidity reasons. Read More.
• Negative Sentiment: Rising short interest — short positions rose materially in February to roughly 6.97M shares (~8.4% of shares), with a ~4.4 days‑to‑cover figure, increasing the risk of continued selling pressure or intraday volatility. Read More.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in the stock. Great Lakes Advisors LLC bought a new position in shares of Calumet in the third quarter valued at approximately $3,088,000. Two Seas Capital LP grew its stake in Calumet by 56.9% in the 2nd quarter. Two Seas Capital LP now owns 4,497,609 shares of the oil and gas company’s stock valued at $70,860,000 after buying an additional 1,631,098 shares during the last quarter. Intech Investment Management LLC acquired a new position in Calumet in the 2nd quarter valued at $518,000. AYAL Capital Advisors Ltd bought a new position in Calumet in the 2nd quarter worth $5,278,000. Finally, SP Asset Management LLC acquired a new position in Calumet during the 2nd quarter worth $205,000. Institutional investors and hedge funds own 34.41% of the company’s stock.

About Calumet

Calumet Specialty Products Partners, L.P. (NASDAQ: CLMT) is an independent provider of high-value, essential product solutions derived from both petroleum and renewable feedstocks. The company operates an integrated network of manufacturing plants, blending terminals and storage facilities across North America, delivering customized products and technical services to industrial, automotive, consumer and agricultural end markets. By leveraging its scale and technical expertise, Calumet tailors supply chain and formulation solutions to meet stringent regulatory and performance requirements.

Calumet’s product portfolio includes specialty lubricants and base oils for high-performance applications; process oils and waxes for food-grade, cosmetic and packaging uses; industrial solvents and cleaning solutions; and fuel additives designed to optimize engine performance and emissions.